{
    "clinical_study": {
        "@rank": "48523", 
        "arm_group": [
            {
                "arm_group_label": "DA-3801 injection", 
                "arm_group_type": "Experimental", 
                "description": "Recominant human follicle stimulating hormone 75 IU/day is injected for 14 days"
            }, 
            {
                "arm_group_label": "Gonal-F\u00ae", 
                "arm_group_type": "Active Comparator", 
                "description": "75 IU/day is injected for 14 days"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a phase III comparative study to evaluate the effectiveness and safety of DA-3801 in\n      treatment of the patients with WHO Group II anovulatory infertility failing to clomiphene\n      citrate treatment. The study is conducted with following methods: open label,\n      active-controlled, randomized, parallel group, comparative."
        }, 
        "brief_title": "A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F\u00ae", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Infertility", 
            "Anovulation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anovulation", 
                "Infertility"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  WHO group II\n\n          -  Clomiphene citrate resistance\n\n          -  BMI: 17~29 kg/m^2\n\n          -  Irregular menstrual cycle\n\n          -  Normal blood concentration of FSH, E2, prolactin and TSH\n\n        Exclusion Criteria:\n\n          -  Uncontrolled endocrine disease\n\n          -  Ovarian cystic tumor which are NOT related to PCOS\n\n          -  Severe endometriosis\n\n          -  Chronic cardiovascular disease, liver complaint"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "38 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "93", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820728", 
            "org_study_id": "DA3801_CA_III (Version 4.0)"
        }, 
        "intervention": [
            {
                "arm_group_label": "DA-3801 injection", 
                "intervention_name": "DA-3801 Injection", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Gonal-F\u00ae", 
                "intervention_name": "Gonal-F\u00ae", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital Institutional Review Board"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase III Clinical Study for the Comparison Evaluation of DA-3801 and Gonal-F\u00ae in Infertile Female Patients With Chronic Anovulation Syndrome", 
        "overall_official": [
            {
                "affiliation": "Dongguk University Hospital", 
                "last_name": "Eung Gi Min, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Seoul National University Bundang Hospital", 
                "last_name": "Chang Suk Suh, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Samsung Medical Center", 
                "last_name": "Doo Seok Choi, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Asan Medical Center", 
                "last_name": "Chung Hoon Kim, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Gachon University Gil Hospital", 
                "last_name": "Jong Min Park, M.D.,Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ajou University School of Medicine", 
                "last_name": "Kyung Joo Hwang, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The ovulation rate after 3 cycles of the injection", 
            "safety_issue": "No", 
            "time_frame": "5 weeks maximum"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820728"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Total dose used, IU (International Unit)", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "measure": "Duration of stimulation, days", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "measure": "Threshold dose, IU", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "description": "Counter the number of follicles which are 12 mm, 15 mm, 18 mm in diameter", 
                "measure": "Number of follicles", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }
        ], 
        "source": "Dong-A Pharmaceutical Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dong-A Pharmaceutical Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}